Preparation and Characterization of Latent α1-Antitrypsin (*)

Members of the serine proteinase inhibitor or serpin superfamily have a common molecular architecture based on a dominant five-membered A β-pleated sheet and a mobile reactive center loop. The reactive center loop has been shown to adopt a range of conformations from the three turn α-helix of ovalbumin to the cleaved or latent inhibitor in which the reactive center loop is fully inserted into the A sheet of the molecule. While the cleaved state can be achieved in all inhibitory serpins only plasminogen activator inhibitor-1 and, more recently, antithrombin have been shown to adopt the latent conformation. We show here that the archetypal serpin, α1-antitrypsin, can also be induced to adopt the latent conformation by heating at high temperatures in 0.7 M citrate for 12 h. The resulting species elutes at a lower sodium chloride concentration on an anion-exchange column and has a more cathodal electrophoretic mobility on non-denaturing polyacrylamide gel electrophoresis and isoelectric focusing than native M antitrypsin. Latent antitrypsin is inactive as an inhibitor of bovine α-chymotrypsin, is stable to unfolding with 8 M urea, and is more resistant to heat-induced loop-sheet polymerization than native but less resistant than cleaved antitrypsin. The reactive center loop of latent antitrypsin is inaccessible to proteolytic cleavage, and its occupancy of the A sheet prevents the molecule accepting an exogenous reactive center loop peptide. The activity of latent antitrypsin may be increased from <1% to approximately 35% by refolding from 6 M guanidinium chloride.

[1]  Thomas E. Creighton,et al.  Protein structure : a practical approach , 1997 .

[2]  R. Carrell,et al.  Thromboembolic disease due to thermolabile conformational changes of antithrombin Rouen-VI (187 Asn-->Asp) , 1994, The Journal of clinical investigation.

[3]  J. Huntington,et al.  Alpha 1-proteinase inhibitor variant T345R. Influence of P14 residue on substrate and inhibitory pathways. , 1994, Biochemistry.

[4]  J. Potempa,et al.  The serpin superfamily of proteinase inhibitors: structure, function, and regulation. , 1994, The Journal of biological chemistry.

[5]  B. Cooperman,et al.  Crystal structure of an uncleaved serpin reveals the conformation of an inhibitory reactive loop , 1994, Nature Structural Biology.

[6]  W. Hol,et al.  The intact and cleaved human antithrombin III complex as a model for serpin–proteinase interactions , 1994, Nature Structural Biology.

[7]  P. Liljeström,et al.  Plasminogen-activator inhibitor type 2 (PAI-2) is a spontaneously polymerising SERPIN. Biochemical characterisation of the recombinant intracellular and extracellular forms. , 1993, European journal of biochemistry.

[8]  C. Hack,et al.  A hinge region mutation in C1-inhibitor (Ala436-->Thr) results in nonsubstrate-like behavior and in polymerization of the molecule. , 1993, The Journal of biological chemistry.

[9]  P. Stein,et al.  Mobile reactive centre of serpins and the control of thrombosis , 1993, Nature.

[10]  D. Lomas,et al.  Alpha 1-antitrypsin Siiyama (Ser53-->Phe). Further evidence for intracellular loop-sheet polymerization. , 1993, The Journal of biological chemistry.

[11]  M. Delarue,et al.  Crystal structure of cleaved bovine antithrombin III at 3.2 A resolution. , 1993, Journal of molecular biology.

[12]  D. Lomas,et al.  Effect of the Z mutation on the physical and inhibitory properties of alpha 1-antitrypsin. , 1993, Biochemistry.

[13]  W. Poller,et al.  The molecular basis of α1-antichymotrypsin deficiency in a heterozygote with liver and lung disease , 1993 .

[14]  D. Lomas,et al.  The mechanism of Z α1-antitrypsin accumulation in the liver , 1993, Nature.

[15]  R. Huber,et al.  Crystal structure of cleaved equine leucocyte elastase inhibitor determined at 1.95 A resolution. , 1992, Journal of molecular biology.

[16]  R. Carrell,et al.  Serpins: mobile conformations in a family of proteinase inhibitors , 1992, Current Biology.

[17]  J. Enghild,et al.  Conformation of the reactive site loop of alpha 1-proteinase inhibitor probed by limited proteolysis. , 1992, Biochemistry.

[18]  R. Pain,et al.  Effects of glycosylation on the folding and stability of human, recombinant and cleaved alpha 1-antitrypsin. , 1992, Journal of molecular biology.

[19]  E. Goldsmith,et al.  Structural basis of latency in plasminogen activator inhibitor-1 , 1992, Nature.

[20]  P. Andreasen,et al.  Type‐1 inhibitor of plasminogen activators , 1991, FEBS letters.

[21]  P. Stein,et al.  Mobile reactive centre of serpins and the control of thrombosis , 1991, Nature.

[22]  A G Leslie,et al.  Crystal structure of uncleaved ovalbumin at 1.95 A resolution. , 1991, Journal of molecular biology.

[23]  J. Travis,et al.  Evidence for a tetrahedral intermediate complex during serpin-proteinase interactions. , 1991, The Journal of biological chemistry.

[24]  W. R. Wikoff,et al.  Substrate properties of C1 inhibitor Ma (alanine 434----glutamic acid). Genetic and structural evidence suggesting that the P12-region contains critical determinants of serine protease inhibitor/substrate status. , 1991, The Journal of biological chemistry.

[25]  R. Huber,et al.  Crystal structure of cleaved human alpha 1-antichymotrypsin at 2.7 A resolution and its comparison with other serpins. , 1991, Journal of molecular biology.

[26]  Robert Huber,et al.  Ligand binding: proteinase-protein inhibitor interactions , 1991 .

[27]  P. Gaffney,et al.  Serpin-serine protease binding kinetics: alpha 2-antiplasmin as a model inhibitor. , 1991, Biochemistry.

[28]  D. Lawrence,et al.  Structure-function studies of the SERPIN plasminogen activator inhibitor type 1. Analysis of chimeric strained loop mutants. , 1990, The Journal of biological chemistry.

[29]  R. Huber,et al.  Structural transition of α1‐antitrypsin by a peptide sequentially similar to β‐strand s4A , 1990 .

[30]  A. Leslie,et al.  Crystal structure of ovalbumin as a model for the reactive centre of serpins , 1990, Nature.

[31]  T. Grundström,et al.  Purification of active human plasminogen activator inhibitor 1 from Escherichia coli. Comparison with natural and recombinant forms purified from eucaryotic cells. , 1989, European journal of biochemistry.

[32]  R. Carrell,et al.  Implications of the three-dimensional structure of alpha 1-antitrypsin for structure and function of serpins. , 1989, Biochemistry.

[33]  V. Weiss,et al.  Plasma serine proteinase inhibitors (serpins) exhibit major conformational changes and a large increase in conformational stability upon cleavage at their reactive sites. , 1988, The Journal of biological chemistry.

[34]  K. Okada,et al.  Bovine endothelial cell plasminogen activator inhibitor. Purification and heat activation. , 1988, European journal of biochemistry.

[35]  P. Gettins,et al.  Properties of thrombin- and elastase-modified human antithrombin III. , 1988, Biochemistry.

[36]  E. Levin,et al.  Conversion of the active to latent plasminogen activator inhibitor from human endothelial cells , 1987 .

[37]  A. Aksu,et al.  Amino acid epimerization in planktonic foraminifera suggests slow sedimentation rates for Alpha Ridge, Arctic Ocean , 1986, Nature.

[38]  D. Loskutoff,et al.  Endothelial cells produce a latent inhibitor of plasminogen activators that can be activated by denaturants. , 1985, The Journal of biological chemistry.

[39]  R. Huber,et al.  Human alpha 1-proteinase inhibitor. Crystal structure analysis of two crystal modifications, molecular model and preliminary analysis of the implications for function. , 1984, Journal of molecular biology.

[40]  J. Travis,et al.  [55] Human α1-proteinase inhibitor , 1981 .

[41]  I. Kato,et al.  Protein inhibitors of proteinases. , 1980, Annual review of biochemistry.

[42]  D. Johnson,et al.  Structural evidence for methionine at the reactive site of human alpha-1-proteinase inhibitor. , 1978, The Journal of biological chemistry.

[43]  A. Simoncsits,et al.  Synthesis of pppGpN type dinucleotide derivatives: the 5' end sequence of some RNAs. , 1975, Nucleic acids research.